Statewide

As part of the new institute, UVA's Biocomplexity Institute (BI) is contributing innovative AI research and solutions that will bolster efforts to detect illicit financial activity and address vulnerabilities within global supply chains.

To meet demand, Virginia is scaling up initiatives to develop and expand the workforce, including university-led development programs like the Commonwealth Cyber Initiative (CCI).

A statewide biopharma boom is fueled by talent emerging from Virginia's universities, which provide a steady pipeline of specialized labor.

The Office of the Director of National Intelligence was the catalyst for the institute, with the goal of using next-gen technology to identify potential security threats and protect Americans.

The Office of the Director of National Intelligence was the catalyst for the institute, with the goal of using next-gen technology to identify potential security threats and protect Americans.

The Virginia Catalyst Fund encourages collaboration with over 30 industry partners in collaboration with Virginia universities, including UVA.

UVA is a member of the Virginia Alliance for Semiconductor Technology (VAST), a coalition established to elevate Virginia as a leader on the forefront of the burgeoning semiconductor industry.

The UVA Manning Institute of Biotechnology positions UVA at the very forefront of cutting-edge medicine, such as cellular and gene therapies that revolutionize how diseases are treated and cured.

Melissa M. Lubin will lead UVA's School of Continuing and Professional Studies (SCPS) as Dean with emphasis on programs that respond to both student and workforce demand.

Several companies, including some founded by UVA alumni, are offering guaranteed job interviews to students with certain certificates from the School of Continuing Education and Professional Studies.

Explore 2022's first quarter edition of the Virginia Economic Review featuring a story on UVA and its support for the life sciences industry in Charlottesville (p. 32).

Explore 2022's first quarter edition of the Virginia Economic Review featuring a story on UVA and its support for the life sciences industry in Charlottesville (p. 32).